Literature DB >> 15899088

Using chlamydia positivity to estimate prevalence: evidence from the Chlamydia Screening Pilot in England.

D S LaMontagne1, K A Fenton, J M Pimenta, M Catchpole, P A Rogers, S Randall, W G Hewitt, H Mallinson, G S Underhill, L McLean, T Gleave, V Harindra, A K Ghosh, J M Tobin.   

Abstract

Studies have suggested that positivity can be used to estimate the prevalence of Chlamydia trachomatis in large-scale chlamydia screening programmes. A recent pilot of opportunistic screening in England estimated that the prevalence among 16-24-year-old women in Portsmouth and Wirral was 9.8% and 11.2%, respectively. This study assessed the continued validity of positivity as an approximate for prevalence. We re-analysed data from the Chlamydia Screening Pilot to estimate positivity,calculated as total positive tests divided by total tests, and compared these estimates with the previously reported prevalence, measured as the number of women testing positive divided by the total number of women screened. Overall positivity was 9.4% in Portsmouth and 11.0% in the Wirral; these estimates were not statistically different from prevalence, regardless of health-care setting, age group or symptoms. We conclude that positivity can be used as a proxy for prevalence.

Entities:  

Mesh:

Year:  2005        PMID: 15899088     DOI: 10.1258/0956462053654249

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  1 in total

1.  NICE guidance and the National Chlamydia Screening Programme.

Authors:  Judith Stephenson
Journal:  Sex Transm Infect       Date:  2007-04       Impact factor: 3.519

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.